Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pure Vitality Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. It involves 1 distinct examiner and a single distinct art unit, reflecting a very focused prosecution environment. This concentration suggests that the pending matter is being reviewed by a specialized team dedicated to a specific area of biotechnology.
SAIDHA, TEKCHAND is the busiest examiner, with 1 pending office action. This examiner is the sole point of contact for the company's pending prosecution, making the outcome of this single action critical for the portfolio. For the practitioner, this means that all efforts must be directed toward satisfying the requirements of this specific individual. The presence of only a single pending office action indicates a highly targeted and limited engagement with the patent office at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAIDHA, TEKCHAND | 1 | 82.9% | +14.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18462772 | COMPOSITIONS AND METHODS FOR TREATMENT OF SENSITIVE SKIN | SAIDHA, TEKCHAND | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18462772 | COMPOSITIONS AND METHODS FOR TREATMENT OF SENSITIVE SKIN | SAIDHA, TEKCHAND | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18462772 | COMPOSITIONS AND METHODS FOR TREATMENT OF SENSITIVE SKIN | SAIDHA, TEKCHAND | 1654 | §102§112 | Non-Final OA | — | Pending | Sep 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPure Vitality Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Tekchand Saidha has the most, with 1 of Pure Vitality Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
